A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
for Hypercholesterolaemia
26 locations incl. Foley
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 75
Code: NCT07610278·Phase 2·Recruiting·Listed May 27, 2026